Webinar on CRISPR/Cas9 on May 11
The American Association for the Advancement of Science and the journal Science will present a free, one-hour webinar about CRISPR/Cas9 in drug discovery at noon Eastern on May 11.
Here’s an excerpt from the registration page:
During this webinar, our expert panel will address:
- Areas of the drug discovery process where gene editing will have the most immediate and long term impact
- The current and future role of CRISPR/Cas9 in target discovery, hit identification, and lead optimization (compared with siRNA screening)
- The challenges that CRISPR/Cas9 brings to screening and assay development, particularly with respect to cell analysis
- The importance of carrying out binding studies following gene editing.
The speakers will be Lorenz Mayr of AstraZeneca and Ralph Garippa of Memorial Sloan Kettering Cancer Center.